why choose us

First received: May 19, 2023

Clinical Trial: Canagliflozin With Gemcitabine in Pancreatic Carcinoma

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Pancreatic Cancer

Study Type: INTERVENTIONAL


Official Title: Clinical Study of Capeline Combined With Gemcitabine in the Treatment of Pancreatic Cancer

Brief Summary: Gemcitabine-based chemotherapy or combination with FOLFIRINOX is the leading treatment of pancreatic cancer.However, the overall response rate of pancreatic cancer to gemcitabine is less than 20%.Resistance to gemcitabine is the most important reason.There is an urgent need to develop new combination therapies to improve the efficiency of chemotherapy, avoid toxicity limitations, and improve the overall prognosis of pancreatic cancer.At present, it has been found that canagliflozin can reduce the expression level…

Read more